Trial Profile
Antimicrobial De-escalation Strategy in Medical Patients.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2010
Price :
$35
*
At a glance
- Drugs Meropenem (Primary) ; Piperacillin/tazobactam (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- 17 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Feb 2010 New trial record